gene amplification in patients with metastatic cancer

gene amplification in patients with metastatic cancer

Purpose Neurotropic tropomyosin receptor kinase (NTRK) fusions have been identified in a variety of cancers, and tyrosine kinase inhibitors targeting the tropomyosin receptor kinase (TRK) receptor are currently in clinical trials. However, no reports are available on the effects of NTRK gene amplifi...

Full description

Bibliographic Details
Main Authors: Su Jin Lee, Nayoung K. D. Kim, Se-Hoon Lee, Seung Tae Kim, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Woong Yang Park, Hee Jin Bang, Kyoung-Mee Kim, Keunchil Park, Jeeyun Lee
Format: Article
Language:English
Published: Sungkyunkwan University School of Medi 2017-09-01
Series:Precision and Future Medicine
Subjects:
NGS cancer panel
gene amplification
TRK immunohistochemistry
Online Access:http://www.pfmjournal.org/upload/pdf/pfm-2017-00142.pdf

Internet

http://www.pfmjournal.org/upload/pdf/pfm-2017-00142.pdf

Similar Items